microRNA, miR-26b, improves the sensitivity of hepatocellular carcinoma to doxorubicin by USP9X-dependent degradation of p53 as well as autophagy regulation (Chen et al., 2021). The gene discussed is TP53; the disease is hepatocellular carcinoma.